June 24th, 2024:
Today Sahla El Mahdaoui defended her PhD thesis "Immunological effects of anti-CD20 therapy in multiple sclerosis". There was an impressive attendance and Sahla helped us all in the best possible way to understand the immunological mechanisms behind the treatment. Her study definitely has contributed to a greater understanding of MS disease pathogenesis and treatment with anti-CD20 antibodies.
About the Danish Multiple Sclerosis Center
The Danish Multiple Sclerosis Center (DMSC) is the leading center for treatment and research in multiple sclerosis in Denmark, and has been awarded Global Excellence in Health.
DMSC provides care for more than 3,500 MS patients, offering both basic and highly specialized therapy. More than 40 employees at the DMSC are engaged in research activities. The focus of the research in DMSC is clinical research, and translational research aiming at implementing the findings from the multidisciplinary research unit of DMSC into new therapies of MS.
How to Find Us
The DMSC is located at Rigshospitalet, Nordre Ringvej 57, 2600 Glostrup, Denmark.
The DMSC Clinic is situated at entrance 3, 6th floor, Red Center (Valdemar Hansens Vej 13), the Clinical Diagnostic and Research Laboratories at entrance 5, 7th floor, Green Center (Valdemar Hansens Vej 17) and the Danish MS Registry at entrance 8, 2th floor (Valdemar Hansens Vej 2).